Skip to main content
logo
ImmuPharma plc (AIM:IMM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
3.325
+0.120 (3.74%)
Sep 25, 2026, 1:42 PM GMT

ImmuPharma Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
203157617
Market Cap Growth
-63.92%521.13%-27.71%13.16%-62.85%-50.56%
Enterprise Value
193147613
Last Close Price
0.030.060.010.020.020.07

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-48.0448.0448.0448.0448.04
PS Ratio
-----139.54
PB Ratio
11.0045.38-9.246.572.433.74
P/TBV Ratio
11.0045.38-6.852.503.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----109.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.38-1.970.44-0.20-0.26-0.37
Net Debt / EBITDA Ratio
0.290.540.110.070.230.33
Net Debt / FCF Ratio
0.380.570.130.150.270.34
Asset Turnover
-----0.01
Quick Ratio
0.781.460.440.541.391.76
Current Ratio
1.341.520.580.811.612.11
Return on Equity (ROE)
-432.82%-2510.61%-967.41%-163.24%-109.77%-116.20%
Return on Assets (ROA)
-63.37%-110.91%-76.76%-57.18%-37.97%-38.13%
Return on Capital Employed (ROCE)
-130.20%-368.90%418.40%-290.00%-120.00%-116.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-23.32%-5.80%-49.49%-42.09%-62.07%-49.49%
FCF Yield
-9.23%-7.62%-35.29%-19.65%-39.99%-29.57%
Buyback Yield / Dilution
-18.34%-17.81%-15.04%-19.51%-20.60%-25.47%